Credit Suisse analyst Lorenzo Biasio maintained a Buy rating on Illumina (ILMN) today and set a price target of $340.00. The company’s shares closed last Monday at $297.00.
According to TipRanks.com, Biasio is a 3-star analyst with an average return of 3.5% and a 57.0% success rate. Biasio covers the Healthcare sector, focusing on stocks such as Coherus Biosciences, Clovis Oncology, and Merck & Company.
Illumina has an analyst consensus of Strong Buy, with a price target consensus of $340.14, implying a 14.8% upside from current levels. In a report issued on October 25, Guggenheim also initiated coverage with a Buy rating on the stock with a $350.00 price target.
See today’s analyst top recommended stocks >>
Illumina’s market cap is currently $43.59B and has a P/E ratio of 45.33. The company has a Price to Book ratio of 9.82.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Illumina is an online portal that helps educators identify and resolve learning problems of their students. It utilizes enjoyable games to motivate students and analyze their interactions to determine their skills.
